Magle Life Sciences is a leading healthcare innovation company dedicated to developing high-quality, life-changing medical solutions through scientific excellence. The Group’s proprietary technology platform, degradable starch microspheres (DSM), serves as a basis for the development of diagnostic amylase quantification assays and of screening methods in forensic biology.